Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids.

Yuan-Hung WuHeng-Sheng ChaoChi-Lu ChiangYung-Hung LuoChao-Hua ChiuSang-Hue YenChun-Yu LiuJeng-Fong ChiouThierry BurnoufYin-Ju ChenPeng-Yuan WangTsu-Yi ChaoShih-Ming HsuLong-Sheng Lu

Published in: Thoracic cancer (2023)

This study supports the potential of circulating tumor cell-derived organoids to inform personalized treatment for advanced thymic malignancies. Further validation of this proof of concept finding is ongoing.

Keyphrases

circulating tumor
circulating tumor cells
cell free
papillary thyroid
squamous cell
combination therapy
squamous cell carcinoma
risk assessment
human health
young adults